Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LacTEST vs HBT for Hypolactasia Diagnosis
NCT02636413Phase 4Completed
- Sponsor
- Venter Pharma
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Gaxilose in lactose intolerance (2 arms), sponsored by Venter Pharma. Primary endpoint: Visual Analogical Scale up to 10 months. Started Oct 2015; status: completed.
02
Drugs
Gaxilose
03
Conditions
lactose intolerance
Beyond the preview
Go deeper on NCT02636413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02636413.